Page 66 - P4403.14_V87_YOUROTC_Book DECEMBER_2023 NI PRINT Final 23

ARE YOUR

PATIENTS

TREATING THE

CAUSE OF THEIR

FREQUENT

HEARTBURN?

FREQUENT HEARTBURN
OCCURS MORE THAN
ONCE A WEEK

NO OTHER HEARTBURN
REMEDY LASTS LONGER
WITHOUT PRESCRIPTION 1,2

Esomeprazole
Heartburn is caused by stomach acid rising up (reflux)
into the oesophagus. Frequent heartburn makes the
oesophagus sensitive to acid so it doesn’t take much to
trigger the pain.
NICE guidelines recommend PPIs as first line treatment
for frequent heartburn. Nexium Control treats the cause
3
and symptoms of frequent heartburn by reducing the
production of stomach acid.

DISCOVER THE SCIENCE
OF NEXIUM CONTROL

1. Lind T et al. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol
Ther 2000; 14: 861-7 2. Rohss K et al. Esomeprazole 20mg provides more effective instragastric acid control than maintenance-dose rabeprazole, lansoprazole or
pantaprazole in healthy volunteers. Clin Drug Invest 2004; 24(1): 1-7. 3. NICE guidelines CG184 Sept 2014.
Nexium Control 20 mg gastro-resistant tablets. Active ingredient: Esomeprazole Indications: The short term treatment of reflux symptoms (e.g. heartburn and
acid regurgitation) in adults. Legal category: P: 28s tablets. PL holder: Haleon UK Trading Limited, The Heights, Weybridge, Surrey, KT13 0NY, U.K.
1. Lind T et al. Esomeprazole provides improved acid control vs. omeprazole in
Information about this product, including adverse reactions, precautions, contraindications, and method of use can be found at:
patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol
https://www.medicines.org.uk/emc/product/14465/smpc Ther 2000; 14: 861-7 2. Rohss K et al. Esomeprazole 20mg provides more effective
instragastric acid control than maintenance-dose rabeprazole, lansoprazole or
Trade marks are owned by or licensed to the Haleon group of companies. PM-GB-NEX-23-00012.
pantaprazole in healthy volunteers. Clin Drug Invest 2004; 24(1): 1-7. 3. NICE
guidelines CG184 Sept 2014.
Nexium Control 20 mg gastro-resistant tablets. Active ingredient: Esomeprazole
Indications: The short term treatment of reflux symptoms (e.g. heartburn and
acid regurgitation) in adults. Legal category: P: 28s tablets. PL holder: Haleon UK
Trading Limited, The Heights, Weybridge, Surrey, KT13 0NY, U.K.
Information about this product, including adverse reactions, precautions,
Numark, Hams Hall Distribution Park, Edison Road, contraindications, and method of use can be found at:
Coleshill, Birmingham, B46 1DA. https://www.medicines.org.uk/emc/product/14465/smpc
Numark is a division of PHOENIX Healthcare Trade marks are owned by or licensed to the Haleon group of companies. PM-GB-
NEX-23-00012.
Distribution Limited
Tel 0800 783 5709
Registered in England and Wales No 00129370
Refer to NumarkNet for terms and conditions
13/11/2023 15:07:33
P4403.14_V87_YOUROTC_Book DECEMBER_2023 NI.indd 66 13/11/2023 15:07:33
P4403.14_V87_YOUROTC_Book DECEMBER_2023 NI.indd 66